PEPsy-CM study protocol: impact of a 3-year program for early psychosis based on case-management on relapse rate, a French multicenter randomized trial.
Aurélie Schandrin, Julie Jourdan, Sihame Chkair...
https://pubmed.ncbi.nlm.nih.gov/40375175/Actively Recruiting
Led by Centre Hospitalier Universitaire de Nīmes · Updated on 2025-12-31
256
Participants Needed
6
Research Sites
8 weeks
Total Duration
Researchers are studying the impact of specialized case managers on young people aged 16 to 30 who are experiencing their first psychotic episode. The goal is to improve care by providing personalized support, education about the illness and treatments, family involvement, and help with social and work reintegration. This study compares this case management approach to the usual care system and aims to reduce the rate of psychotic episode recurrence over three years. Participants will be randomly assigned to either receive regular, personalized follow-up from a trained case manager updated every three months or continue with standard care without this intervention. The study is open-label with blinded evaluation and takes place across multiple centers. The intervention focuses on early, proactive support according to good practice guidelines. During the three-year study period, participants will have assessments every six months that include psychiatric evaluations, monitoring of hospitalizations, adherence to treatment, social and occupational functioning, quality of life, and any adverse events. Researchers will track the number and type of psychotic recurrences, hospital admissions, treatment compliance, and overall socio-professional functioning. The study includes detailed clinical and laboratory assessments to understand the effects of the intervention over time.
CONDITIONS
Evaluation of the Impact of Case Manager Intervention on the 3-year Psychotic Episode Recurrence Rate in Patients Aged 16 to 30 Years With a First Psychotic Episode.
A
Aurélie Schandrin
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Centre Hospitalier Universitaire de Nīmes
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 3 years
Participants in the experimental group receive regular and personalized follow-up by a case manager using a case management approach, updated every 3 months. Participants in the control group receive standard care without case manager intervention.
Quarterly visits for up to 3 years
Duration - Up to 3 years total including treatment
Participants are monitored for recurrence of psychotic episodes and other health outcomes after completion of the treatment period.
Assessments every 6 months from inclusion
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Aurélie Schandrin, Julie Jourdan, Sihame Chkair...
https://pubmed.ncbi.nlm.nih.gov/40375175/Centre Hospitalier Universitaire de Nīmes
Lead Sponsor